Everfront Biotech Inc. focused on new drug discovery and development. Our R&D team has been established since 2010. We are developing small molecules that have the potential to bring safe and effective treatments for the patients with cancers, neuronal degenerative diseases and rare diseases. Our team is specialized in pre-clinical study design, CMC;Chemistry, Manufacturing, and Control, IND-submission, and the clinical trial design and conduction.

Up to now, total three clinical trials are performing in Taiwan under the approval of USFDA and TFDA. Besides, five more products are under the pre-clinical status. Progressively, we are devoted in developing the technology that have commercial application potentials to help the people with urgent medical needs.